Search
Filter by Topic
- (-) Remove Reproduction filter Reproduction
- Disorders (28) Apply Disorders filter
- People (19) Apply People filter
- Technologies (12) Apply Technologies filter
- Legal (11) Apply Legal filter
- Processes (11) Apply Processes filter
- Ethics (9) Apply Ethics filter
- Experiments (7) Apply Experiments filter
- Organizations (5) Apply Organizations filter
- Outreach (5) Apply Outreach filter
- Theories (5) Apply Theories filter
- Publications (4) Apply Publications filter
- Religion (3) Apply Religion filter
- Organisms (2) Apply Organisms filter
- Reproductive Health Arizona (1) Apply Reproductive Health Arizona filter
Filter by Format
US Regulatory Response to Thalidomide (1950-2000)
Thalidomide, a drug capable of causing fetal abnormalities (teratogen), has caused greater than ten thousand birth defects worldwide since its introduction to the market as a pharmaceutical agent. Prior to discovering thalidomide's teratogenic effects in the early 1960s, the US Food and Drug Administration (FDA) did not place regulations on drug approval or monitoring as it later did. By 1962, approximately 20,000 patients in the US had taken thalidomide as part of an unregulated clinical trial before any actions were taken to stop thalidomide's distribution.
Format: Articles
Subject: Legal, Reproduction
Gestational Diabetes
Gestational diabetes is a medical condition that causes blood sugar levels to become abnormally high, which manifests for the first-time during pregnancy and typically disappears immediately after birth for around ninety percent of affected women. While many women with the condition do not experience any noticeable symptoms, some may experience increased thirst and urination.
Format: Articles
Subject: Reproduction, Disorders